Page 94 - Applied Computer Science News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Applied computer science. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Applied Computer Science Today - Breaking & Trending Today

Applied UV, Inc.: Applied UV Receives Patent for Pathogen Destroying Devices in China


Applied UV, Inc.: Applied UV Receives Patent for Pathogen Destroying Devices in China
Patents for Disinfection Technology Addressing Global Challenge of Controlling the Spread of Emerging Pathogens
MOUNT VERNON, NY / ACCESSWIRE / April 12, 2021 / Applied UV, Inc. (NASDAQ:AUVI) ( Applied UV or the Company ), an infection control technology company that applies the power of narrow-range ultraviolet light ( UVC ) for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, today announced that the
Chinese Patent office has issued a notice granting Applied UV s patent application for its core pathogen destroying device.
We have always maintained that a strong and growing intellectual property portfolio is one of our key assets and will enable us to maintain a sustainable competitive advantage while establishing barriers of entry to future competitors, said Max Munn, President of Applied ....

United States , South Korea , Max Munn , Sterilumen Airocide , Kevin Mcgrath , Kostenloser Wertpapierhandel , Company Portfolio Of Patents , Munn Works , Gulf Cooperation Council , Uv Inc , Company Lumicide , European Union , Sterilumen Inc , Emerging Pathogens , Chinese Patent , Sterilumen Disinfecting , Data Driven Disinfection , Lumicide Drain , ஒன்றுபட்டது மாநிலங்களில் , தெற்கு கொரியா , அதிகபட்சம் முன் , கெவின் மக்ர்யாத் , முன் வேலை செய்கிறது , வளைகுடா ஒத்துழைப்பு சபை , ஊவ் இன்க் , ஐரோப்பிய தொழிற்சங்கம் ,

Applied DNA Sciences, Inc. and Takis Biotech/Evvivax: Applied DNA and Evvivax Announce Positive Preliminary Results of Phase I Clinical Trial for LinearDNA COVID-19 Vaccine Candidate in Felines


Applied DNA Sciences, Inc. and Takis Biotech/Evvivax: Applied DNA and Evvivax Announce Positive Preliminary Results of Phase I Clinical Trial for LinearDNA COVID-19 Vaccine Candidate in Felines
- Strong Neutralizing Antibody Titer Elicited Across Cohort -
Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA or the Company ), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, and its program development partner, Evvivax, S.R.L. ( Evvivax ), today announced positive preliminary Phase I clinical trial results for a LinearDNA COVID-19 vaccine candidate (the vaccine candidate ) in adult domestic felines. Results following administration of a single prime dose of the vaccine candidate on day 1 in late February indicate that the LinearDNA vaccine candidate is well-tolerated by the cohort. A SARS-CoV-2 neutralization assay was conducted by the Cornell University Animal Health Diagnostic Center at the College of Veterinary Medicine 20 days after prime dose ....

United Kingdom , Joseph Impellizeri , Jamesa Hayward , Antonella Conforti , Luigi Aurisicchio , Us Department Of Agriculture , Sciences Inc , Drug Administration , Securities Exchange , Cornell University Animal Health Diagnostic Center , College Of Veterinary Medicine , Candidate Well Tolerated , Polymerase Chain Reaction , Veterinary Medicine , Diego Diel , Associate Professor , Cornell University College , Population Medicine , Guardian Veterinary Specialists , Trial Supervising Investigator , Takis Biotech , Coronavirus Variant Found , First Time , Russell Microcap , Therapeutic Veterinary Cancer Vaccines , Securities Act ,

Umbra Applied Technologies Group Inc.: UAT Group, Inc. Completes Bid to Acquire Orthopedic Implant Company


Umbra Applied Technologies Group Inc.: UAT Group, Inc. Completes Bid to Acquire Orthopedic Implant Company
Tampa, Florida (Newsfile Corp. - March 16, 2021) - Umbra Applied Technologies Group, Inc. (OTC Pink: UATG) (UAT Group), announced today that it has initiated the acquisition of the Texas based company Ossifix Technologies, Inc.
The Ossix Orthopedics line of products will compete in one of the fastest growing, emerging markets, specically, the resorbable implant market, in three distinct surgical segments; orthopedic, dental, and general. Ossifix products are designed to be used in hospitals, ambulatory surgical centers, and specialty clinics. Distribution is scheduled throughout North America, and globally in Latin America, Europe, Asia Pacic, as well as the Middle East and Africa. This global market is currently experiencing an estimated growth of 14% per year to reach $4.696 billion US this year. ....

United States , Kostenloser Wertpapierhandel , Asia Pacic , Mark Estrada , Ossifix Technologies Inc , Company Biotech , Umbra Applied Technologies Group Inc , Florida Newsfile Corp , Umbra Applied Technologies Group , Applied Technologies Group , Ossifix Technologies , Ossix Orthopedics , North America , Latin America , Middle East , Executive Officer , Alex Umbra , Ossifix Orthopedics , Ossifix Orthopedics Pin , Plate Systems , Umbra Applied Technologies , Tampa Florida , Media Contact , ஒன்றுபட்டது மாநிலங்களில் , குறி எஸ்ட்ராடா , நிறுவனம் பயோடெக் ,